ICU Medical (NASDAQ:ICUI) Sets New 52-Week Low - Here's Why

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $132.39 and last traded at $136.59, with a volume of 221190 shares trading hands. The stock had previously closed at $137.27.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ICUI. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. KeyCorp decreased their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Raymond James set a $97.00 price objective on ICU Medical in a research report on Wednesday, March 12th. Finally, StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Friday. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $162.67.

ICU Medical Price Performance

The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The business has a 50 day moving average price of $141.24 and a 200-day moving average price of $156.12. The company has a market capitalization of $3.33 billion, a price-to-earnings ratio of -29.62 and a beta of 0.86.

Hedge Funds Weigh In On ICU Medical

Institutional investors and hedge funds have recently modified their holdings of the business. Norges Bank bought a new position in shares of ICU Medical during the 4th quarter worth about $40,151,000. GAMMA Investing LLC boosted its holdings in ICU Medical by 17,559.7% in the first quarter. GAMMA Investing LLC now owns 99,424 shares of the medical instruments supplier's stock worth $138,060,000 after acquiring an additional 98,861 shares in the last quarter. Point72 Asset Management L.P. grew its stake in ICU Medical by 63.2% in the fourth quarter. Point72 Asset Management L.P. now owns 245,340 shares of the medical instruments supplier's stock valued at $38,069,000 after acquiring an additional 95,030 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock valued at $83,788,000 after acquiring an additional 82,982 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of ICU Medical during the fourth quarter worth approximately $10,003,000. 96.10% of the stock is currently owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.